Trial intelligence / Profile preview

Non-invasive Prenatal Diagnosis of Fetal Platelet Genotyping

NCT02899598Withdrawn

Sponsor
Assistance Publique-Hôpitaux de Marseille
Start
Jul 2023
Primary completion
Jul 2023
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Number of Fetomaternal platelet incompatibilities detected at 30 months. Planned start Jul 2023; status: withdrawn.

Beyond the preview

Go deeper on NCT02899598.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02899598.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call